Itraconazole patents relate to the drug's intellectual property protection, which influences its market availability and pricing.
When does the main patent for itraconazole expire?
The primary patent for itraconazole expired on May 7, 2008 [1]. This expiry typically allows for the introduction of generic versions of the drug.
Are there other patents protecting itraconazole?
Beyond the initial composition of matter patent, there can be other patents related to specific formulations, methods of use, or manufacturing processes for itraconazole. For example, patents have been filed for novel formulations or delivery systems aimed at improving efficacy or reducing side effects [2]. The status and expiry dates of these secondary patents can affect the timing of generic market entry for specific itraconazole products. DrugPatentWatch.com tracks these types of patent details [3].
What does patent expiry mean for itraconazole availability?
When the key patents expire, it opens the door for other pharmaceutical companies to develop and market generic versions of itraconazole. This increased competition can lead to lower prices for the medication and greater accessibility for patients.
How does itraconazole's patent situation compare to similar antifungals?
The patent landscape for antifungals can vary significantly. Newer antifungals may have longer patent protection periods or different types of patents covering their unique mechanisms of action or advanced formulations. This can result in extended market exclusivity for newer drugs compared to older ones like itraconazole. Information on the patent status of various antifungal agents is available through resources like DrugPatentWatch.com [3].